Genetic Interactions of Progranulin Across the ALS-FTD Spectrum and Beyond

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Progranulin (PGRN) mutations are a key cause of frontotemporal dementia (FTD).
• PGRN has demonstrated neuroprotective properties, but its broader role in neurodegeneration requires further study.
• Mammalian models are limited for comprehensive analysis of PGRN's genetic interactions.

Purpose of the Study:

• To investigate the neuroprotective role of progranulin (PGRN) in various neurodegenerative disease models.
• To map the genetic interactions of PGRN using a model organism.
• To assess the impact of PGRN overexpression and loss-of-function on disease phenotypes.

Main Methods:

• Utilized the nematode *C. elegans* as a model organism for genetic analysis.
• Employed multiple genetic models of neurodegenerative diseases.
• Examined the effects of PGRN overexpression and PGRN loss-of-function on disease phenotypes.

Main Results:

• Overexpression of PGRN demonstrated a protective effect across all tested neurodegenerative models.
• Loss of PGRN function exacerbated disease phenotypes in most models, with exceptions in three specific models.
• Identified specific genetic interactions of PGRN in the context of neurodegeneration.

Conclusions:

• *C. elegans* is an efficient model for mapping PGRN's genetic interactions in neurodegenerative diseases.
• PGRN plays a complex role in neurodegeneration, with its function dependent on expression levels and genetic context.
• Further research in *C. elegans* can elucidate PGRN's mechanisms in neuronal health and disease.